Antiphospholipid syndrome is considered a high risk factor for any kind of surgery. Considering that all solid organ transplants are critically dependent on the patency of vascular anastomosis, there is much concern about the consequences this pro-thrombotic condition may have on transplantation. Relatively little information is available in the literature assessing the real risk that antiphospholipid syndrome or the presence of antiphospholipid antibodies represent in solid organ transplantation. The aim of this article is to review the literature related to transplantation of solid organs in patients diagnosed with antiphospholipid syndrome or patients with positive antiphospholipid antibodies.
TalentiDAFalkGWCareyWDMarchantK. Anticardiolipin antibody-associated cerebral infarction in cirrhosis: Clearance of anticardiolipin antibody after liver transplantation. Am J Gastroenterol1994; 89: 785–788.
6.
YasutomiMEgawaHKobayashiYOikeFTanakaK. Living donor liver transplantation for Budd-Chiari syndrome with inferior vena cava obstruction and associated antiphospholipid antibody syndrome. J Pediatr Surg2001; 36: 659–662.
7.
AyalaRMartínez-LópezJCedenaT. Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients. BMC Gastroenterol2011; 11: 130–130.
8.
Ordi-RosJVillarrealJMonegalFSauledaSEstebanIVilardellM. Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: Characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol2000; 7: 241–244.
9.
HaradaMFujisawaYSakisakaS. High prevalence of anticardiolipin antibodies in hepatitis C virus infection: Lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol2000; 35: 272–277.
10.
LiaskosCRigopoulouEZachouK. Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J Autoimmun2005; 24: 251–260.
11.
ZachouKLiaskosCRigopoulouE. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol2006; 119: 203–212.
12.
MangiaAMargaglioneMCascavillaI. Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol1999; 94: 2983–2987.
PascualMThadhaniRLaposataM. Anticardiolipin antibodies and hepatic artery thrombosis after liver transplantation. Transplantation1997; 64: 1361–1364.
15.
CollierJDSaleJFriendPJJamiesonNVCalneRYAlexanderGJ. Graft loss and the antiphospholipid syndrome following liver transplantation. J Hepatol1998; 29: 999–1003.
16.
VivarelliMLa BarbaGLegnaniC. Repeated graft loss caused by recurrent hepatic artery thrombosis after liver transplantation. Liver Transpl2003; 9: 629–631.
17.
Van ThielDHGeorgeMBremsJ. Antiphospholipid antibodies before and after liver transplantation. Am J Gastroenterol2003; 98: 460–465.
18.
Furmańczyk-ZawiskaATroninaOBaczkowskaTChmuraADurlikM. The significance of antiphospholipid antibodies in liver recipients. Transplant Proc2013; 45: 1983–1989.
19.
BronsterDJGousseRFassasARandJH. Anticardiolipin antibody-associated stroke after liver transplantation. Transplantation1997; 63: 908–909.
20.
MundoJPerisPMonegalANavasaMCerveraRGuañiabensN. Multifocal avascular necrosis after liver transplantation: An unusual presentation of the antiphospholipid syndrome. Lupus2006; 15: 304–307.
21.
CerveraRRodríguez-PintóIColafrancescoS. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Autoimmun Rev2014; 13: 699–707.
GologorskyEAndrewsDMGologorskyA. Devastating intracardiac and aortic thrombosis: A case report of apparent catastrophic antiphospholipid syndrome during liver transplantation. J Clin Anesth2011; 23: 398–402.
24.
AshersonRAHigenbottamTWDinh XuanATKhamashtaMAHughesGR. Pulmonary hypertension in a lupus clinic: Experience with twenty-four patients. J Rheumatol1990; 17: 1292–1298.
25.
PengoVBiasioloAMarsonPDe SilvestroGAgostiniCLiviU. Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome. Clin Rheumatol1996; 15: 504–507.
ErdozainJGRuiz-IrastorzaGSeguraMI. Cardiac valve replacement in patients with antiphospholipid syndrome. Arthritis Care Res (Hoboken)2012; 64: 1256–1260.
28.
HegdeVAVivasYShahH. Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome—a case-series. Heart Lung Circ2007; 16: 423–427.
29.
FarneyACRogersJStrattaRJ. Pancreas graft thrombosis: Causes, prevention, diagnosis, and intervention. Curr Opin Organ Transplant2012; 17: 87–92.
30.
AdroguéHEMatasAJMcGlennonRC. Do inherited hypercoagulable states play a role in thrombotic events affecting kidney/pancreas transplant recipients?Clin Transplant2007; 21: 32–37.
31.
WullsteinCWoesteGZapletalCDetteKBechsteinWO. Simultaneous pancreas-kidney transplantation in patients with antiphospholipid syndrome. Transplantation2003; 75: 562–563.
32.
FiehnCBreitbartAGermannG. Autologous skin transplantation for widespread cutaneous necrosis in secondary antiphospholipid syndrome. Ann Rheum Dis2001; 60: 908–910.
33.
CanaudGBienaiméFNoëlLH. Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies. Am J Transplant2010; 10: 2051–2060.
34.
McIntyreJAWagenknechtDR. Antiphospholipid antibodies and renal transplantation: A risk assessment. Lupus2003; 12: 555–559.
35.
WagenknechtDRFastenauDRTorryRJ. Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies. Transpl Int2000; 13(Suppl 1): S78–S81.
36.
DuclouxDPelletEFournierV. Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. Transplantation1999; 67: 90–93.
StoneJHAmendWJCriswellLA. Antiphospholipid antibody syndrome in renal transplantation: Occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am J Kidney Dis1999; 34: 1040–1047.
39.
FormanJPLinJPascualMDentonMDTolkoff-RubinN. Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant2004; 4: 1786–1791.
40.
VaidyaS. Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome. Clin Transplant2012; 26: 853–856.
41.
AndrassyJZeierMAndrassyK. Do we need screening for thrombophilia prior to kidney transplantation?Nephrol Dial Transplant2004; 19(Suppl 4): iv64–iv68.
42.
KfouryETaherASaghiehSOtrockZKMahfouzR. The impact of inherited thrombophilia on surgery: A factor to consider before transplantation?Mol Biol Rep2009; 36: 1041–1051.
43.
MorrisseyPERamirezPJGohhRY. Management of thrombophilia in renal transplant patients. Am J Transplant2002; 2: 872–876.
44.
FriedmanGSMeier-KriescheHUKaplanB. Hypercoagulable states in renal transplant candidates: Impact of anticoagulation upon incidence of renal allograft thrombosis. Transplantation2001; 72: 1073–1078.
45.
PodolakBBlicksteinDInbalA. Renal transplantation in a patient with catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia. Isr Med Assoc J2014; 16: 61–62.
46.
RuffattiAMarsonPValenteM. Plasma exchange in a patient with primary antiphospholipid syndrome undergoing kidney transplantation. Transpl Int2007; 20: 475–477.
47.
ChewCGBannisterKMMathewTHRussGSeymourA. Thrombotic microangiopathy related to anticardiolipin antibody in a renal allograft. Nephrol Dial Transplant1999; 14: 436–438.
48.
LonzeBEZacharyAAMagroCM. Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. Am J Transplant2014; 14: 459–465.
49.
LonzeBESingerALMontgomeryRA. Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med2010; 362: 1744–1745.
50.
CanaudGKamarNAnglicheauD. Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes. Am J Transplant2013; 13: 2179–2185.
51.
HadayaKFerrari-LacrazSFumeauxD. Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation. Am J Transplant2011; 11: 2523–2527.
52.
European Renal Best Practice Transplantation Guideline Development Group. ERBP Guideline on the Management and Evaluation of the Kidney Donor and Recipient. Nephrol Dial Transplant2013; 28(Suppl 2): ii1–ii71.
53.
AndrewsPABurnappLManasD. Summary of the British Transplantation Society/Renal Association U.K. guidelines for living donor kidney transplantation. Transplantation2012; 93: 666–673.
54.
Ruiz-IrastorzaGCuadradoMJRuiz-ArruzaI. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus2011; 20: 206–218.
55.
ErkanDLeibowitzEBermanJLockshinMD. Perioperative medical management of antiphospholipid syndrome: Hospital for special surgery experience, review of literature, and recommendations. J Rheumatol2002; 29: 843–849.
56.
GuyattGHAklEACrowtherMGuttermanDDSchuünemannHJ. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012; 141(2 Suppl): 7S–47S.
